Hovakimyan, Armine
Antonyan, Tatevik
Shabestari, Sepideh Kiani
Svystun, Olga
Chailyan, Gor
Coburn, Morgan A.
Carlen-Jones, William
Petrushina, Irina
Chadarevian, Jean Paul
Zagorski, Karen
Petrovsky, Nikolai http://orcid.org/0000-0002-1580-5245
Cribbs, David H.
Agadjanyan, Michael G.
Ghochikyan, Anahit
Davtyan, Hayk http://orcid.org/0000-0001-8554-6456
Funding for this research was provided by:
NIAID/NIH
NIH
NIA/NIH
Article History
Received: 11 April 2019
Accepted: 8 October 2019
First Online: 29 October 2019
Competing interests
: M.G.A. and A.G. are co-founders of Capo Therapeutics that licensed MultiTEP vaccine platform technology from the Institute for Molecular Medicine. The remaining authors declare no financial, commercial and non-financial conflict of interests.